Lawsuits Claim Novo Nordisk, Eli Lilly Failed to Properly Disclose ‘Debilitating’ Side Effects of GLP-1 Weight Loss Drugs
December 3, 2024 Multidistrict litigation alleges Novo Nordisk and Eli Lilly have purposely downplayed the dangerous side effects of weight loss drugs such as Ozempic, Wegovy and Zepbound.